Page last updated: 2024-08-22

rhenium and Neoplasms, Squamous Cell

rhenium has been researched along with Neoplasms, Squamous Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerman, OC; Börjesson, PK; Buijs, WC; de Bree, R; Lang, M; Marres, HA; Munzert, G; Oyen, WJ; Postema, EJ; Roos, JC; van Dongen, GA	1

Trials

1 trial(s) available for rhenium and Neoplasms, Squamous Cell

Article	Year
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Marrow; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Risk Assessment; Sex Factors; Tissue Distribution; Whole-Body Counting	2003

Article

Year

Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:10

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Marrow; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Risk Assessment; Sex Factors; Tissue Distribution; Whole-Body Counting

2003